Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan.

Guangdong Huanan Pharmaceutical Group Co. Ltd., a subsidiary of Guangdong Zhongsheng Pharmaceutical Co., Ltd., is a company headquartered in Dongguan, China, that manufactures pharmaceutical drug products.

Part of Guangdong Zhongsheng Pharmaceutical Co., Ltd., Guangdong Xianqiang Pharmaceutical Co. Ltd. is a Chinese company located in Guangzhou. The firm manufactures and distributes pharmaceutical products. On March 22, 2015 Guangdong Zhongsheng Pharmaceutical Co., Ltd. acquired Guangdong Xianqiang Pharmaceutical Co. Ltd. for $204.63 million.

Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in the manufacture, sale, research and development of medicine. It mainly focuses on Chinese medicines formulations, aid digestion medicines, vitamin medicines, dermatology drugs, anti-parasitic drugs, ophthalmic solution, chemicals and respiratory system drugs. The company was founded on December 31, 2001 and is headquartered in Dongguan, China.

Guangdong Eashu Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of chemical agents, chemical raw materials, and Chinese medicines. It offers medicine in the form of tablets, capsules, and granules. It also provides active pharmaceutical ingredients such as etracaine hydrochloride, carbocisteine, tolbutamide, benzocaine, propafenone hydrochloride, and taurine. The company was founded on October 9, 2000 and is headquartered in Zhaoqing, China.

Beijing Yingkerui Innovative Drug Research Co., Ltd., established on 2015-09-23, Business scope includes medical research and experimental development;technology development,transfer,consult,Serve;Technical testing.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Wuhan Grand Hoyo Co., Ltd. engages in the research, development, and manufacture of the amino acids and their derivatives. Its business scope includes pharmaceutical production; production and sale of food additives; production and sale of feed and feed additives; technology and product development, research, and technical services of bioengineering, new materials, and electronic information; and manufacture and sales of developed product. The company was founded on April 13m 2000 and is headquartered in Wuhan, China.Its products includes Active Pharmaceutical Ingredient (APIs), L-Cysteine and its derivatives, L-Arginine and its derivatives, L-amino acids, Acetyl amino acids, and compound salts of amino acids. The company was founded on April 13m 2000 and is headquartered in Wuhan, China.

Lyrus is a pharmaceutical company that formulates, develops, and markets various nutraceutical and over-the-counter medical products.

Avedro is a privately held medical device and pharmaceutical company advancing the science and technology of corneal cross-linking. Avedro recently completed its US‐based, multi-centered, Phase III studies of corneal cross-linking for the treatment of progressive keratoconus and corneal ectasia following refractive surgery. Outside the United States, Avedro has commercialized both VibeX and its KXL System for performing Lasik Xtra and accelerated cross-linking. Additionally, Avedro is developing the science of Thermo‐biomechanics for therapeutic medical applications. The Keraflex® refractive correction procedure is the first technology developed from the Thermo‐biomechanics platform and is a non‐invasive, incision‐less ophthalmic procedure for flattening the cornea without the removal of tissue. Keraflex offers the unique ability to induce refractive change without weakening the cornea’s biomechanical integrity, as happens with Lasik and other refractive correction procedures. Keraflex is commercially available outside of the United States.

Hunan Jiudian Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products. Its products include pharmaceutical preparations, raw materials, pharmaceutical excipients, plant extracts, anti-infective drugs, anti-allergic drugs, digestive system drugs, respiratory system drugs, cardiovascular and cerebrovascular drugs, gynecological drugs, tonics, and topical plasters. The company was founded on January 19, 2001 and is headquartered in Changsha, China.

Yunpeng Pharmaceutical Group Co., Ltd., established on 1998-09-15, Business scope includes production,Sales:tablet(Contains slow control agent),hard capsule(Contains penicillins),ointment,Babu ointment,cream,plaster,Powder,Psychotropic drugs,stickers,wake up stickers,Cooling patch,medical supplements,inhalation powder,film,Chinese Herbal Medicine,Chinese patent medicine,Granules,API,Chemical Products(Free of Hazardous Chemicals),Medical masks,Class II medical device,Medical plastic products,Medical Packaging Materials;Sales:Health products,herbal tea,Healthy food,disinfection products(Hazardous chemicals excluded),cosmetic,detergent,sanitary material,medical supplies,Pharmaceutical Pilot Products;operate:drug development,Import and export business(Limited to our products),Agricultural product acquisition,Raw and auxiliary materials;Provide medical information consultation and technology transfer,Internet technology innovation platform,Housing rental services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Beipeng Technology Co., Ltd., established on 2007-06-29, Business scope includes technology development,technology transfer,technical consulting,Technical Services;Commissioned processing of chemical products(Removal of hazardous chemicals);sell cleaning supplies,cosmetic.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Henkel AG & Co. KGaA engages in the production, sale, and distribution of home and beauty care products. The firm also provides adhesive technology solutions. It operates through the Adhesive Technologies and Consumer Brands segments. The Adhesive Technologies segment sells adhesives, sealants, and functional coatings for consumers, craftsmen, and industrial applications. The Consumer Brands segment offers branded products for consumers and professional applications for the hairdressing business that includes products for hair care, styling and coloring, as well as detergents and fabric softeners. The company was founded by Fritz Henkel on September 26, 1876 and is headquartered in Dusseldorf, Germany.

Wuhan Wuyao Technology Co., Ltd., established on 2003-06-10, Business scope includes pharmaceutical,chemical industry,medical instruments,product technology development,technology transfer,Technical Services,technical consulting.

Guangzhou Lixin Pharmaceutical Co., Ltd., established on 2003-01-08, Business scope includes research in health science projects,to develop;drug development;Business Management Consulting Services;Planning creative services;Market Research Services;Marketing Planning Service;Mechanical Technology Development Services;Chemical Engineering Research Services;Food Science and Technology Research Services;Chinese patent medicine production;Manufacturing of chemical raw materials;Manufacturing of chemical preparations;Biopharmaceutical Manufacturing;Chinese patent medicine,Chinese Herbal Pieces Wholesale;Western medicine wholesale;Biological product(No vaccine)wholesale;

Venturepharma, Inc. manufactures pharmaceutical products. It offers VP discovery, API development and outsourcing, biopharmaceuticals discovery, RX and OTC. The firm provides products for oncology, CNS, dermnova, diabetes, cardiovascular, respiration and vaccine. The company was founded in 1998 and is headquartered in Haidian, China.

Rhone Poulenc Rorer, a subsidiary of Solvay SA, is a French company that manufactures and distributs pharmaceutical products.

Luojiang Chenming Biological Products Co., Ltd., established on 2001-11-21, The business scope includes amino acid series products,soil conditioner,Water Soluble Amino Acid Fertilizer,Production of Organic Fertilizers,Sales;Manage the export business of the company's self-produced products and technologies and the machinery and equipment required by the company,spare parts,Import business of raw and auxiliary materials and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits import.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Linfen Qilin Pharmaceutical Co., Ltd., established on 2003-03-09, Business scope includes production,processing,wholesale,retail:tablet,hard capsule,Granules,Powder,API(trypsin,carbocisteine);Manage the export business of the company's products(registered capital400ten thousand yuan,In-kind contribution251million for:mechanical equipment,stock,accounted for registered capital62.75%).(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)***

Beijing Jiashi Daheng Pharmaceutical Co. Ltd., part of Beijing Tianchou Jiacheng Technology Development Co. Ltd., is a company headquartered in Beijing, China, that manufactures medicine. Beijing Tianchou Jiacheng Technology Development Co. Ltd. acquired Beijing Jiashi Daheng Pharmaceutical Co. Ltd. from Cachet Pharmaceutical Co., Ltd. on May 05, 2011 for $10.62 million.